Originalartikel 2026

  • Schymik HS, Wrublewsky S, Hring M, Liebisch G, Both S, Gasparoni G, Bickelmann C, Robertson H, Dahlem C, Walter J, Helms V, Laschke MW, Ampofo E, Hoppstädter J, Kiemer AK. 2026. IGF2BP2 deficiency in macrophages impairs migration, reprograms metabolism, and limits tumor progression. Int J Biol Sci 22:2754-2773 

     

  • Berwanger A, Wagner K, Both S, Kany AM, Mazlom K, Anna K.H. Hirsch AKH, Kiemer AK, Empting M. 2026. Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2) Eur J Med Chem 307: 118624

     

  • Gies S, Pohlers M, Tanzer T, Ampofo E, Laschke MW, Schafer M, Kim YJ, Bohle RM, Solomayer EF, Wagner K, Empting, M, Kiemer AK, Walch-Rückheim B. 2026. Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner. Int J Cancer 158:3021.3037 

     
  • Nguyen TT, Hemmer J, Kiemer AK, Diesel B, Lee S. 2026. Biodynamers as prodrugs with controlled uptake and activity. J Control Release 390:114538